Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01871519 · ClinicalTrials.gov registry record · NA

Evaluation of Outcomes for Quality of Life and Activities of Daily Living for BKP in the Treatment of VCFs

A NA study of Cancer and Osteoporosis, sponsored by Medtronic Spinal and Biologics.

Completed
Registry status
NA
Development phase
354
Enrollment target
20
Study locations

NCT01871519: Completed NA study of Cancer and Osteoporosis, sponsored by Medtronic Spinal and Biologics.

NCT01871519 is a NA study of Cancer and Osteoporosis that has completed, run by Medtronic Spinal and Biologics. The registered enrollment target is 354 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (90% lower). The trial reports 20 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01871519, a NA study of Cancer and Osteoporosis, has completed, sponsored by Medtronic Spinal and Biologics.

COMPLETED
Registry status
NA
Development phase
354 participants
Enrollment target
20
Study locations

Study Summary

The study objective is to collect and report 12-month outcomes pertaining to activities of daily living, quality of life, and safety parameters in a Medicare population to be treated with balloon kyphoplasty in the treatment of painful, acute, vertebral body compression fractures (VCFs) associated with either osteoporosis or cancer. The primary objective is to show statistically significant improvement from baseline in the four co-primary endpoints (SF-36v2, PCS, EQ-5D, NRS back pain and ODI) at 3-months; study success will be declared if the primary objective is met. New radiographic fractures, non-surgical management received, VCF-related healthcare resource utilization, and vertebral body height restoration data will also be collected.

Primary Outcome

Back pain was measured using NRS. Patients rated their back pain on a scale from 0-10, with a score of 0 representing "no pain" and a score of 10 representing "pain as bad as it could be."

Conditions Studied

Cancer Osteoporosis Compression Fracture of Vertebral Body

Interventions

  • DEVICE Balloon kyphoplasty

Study Locations (20)

California

  • Washington Radiologist Medical Group - Fremont
  • Sutter Health Sacramento Sierra Region - Sacramento
  • Alta Orthopaedic Medical Group - Santa Barbara
  • Torrance Memorial Medical Center - Torrance

Illinois

  • Central Illinois Neuroscience Foundation - Bloomington
  • Adventist Health Partners - Hinsdale
  • Presence Saint Joseph Medical Center - Joliet
  • Illinois Bone & Joint - Morton Grove

Alabama

  • Alabama Clinical Therapeutics, LLC - Birmingham
  • University of Alabama at Birmingham, Division of Neurological Surgery - Birmingham

Florida

  • Radiology Imaging Specialist of Lakeland - Lakeland
  • The Back Center - Melbourne

Idaho

  • Physicians & Surgeons of Pocatello - Blackfoot
  • St. Luke's Health System - Boise

Michigan

  • Advanced Diagnostic Imaging, PC - Saginaw
  • Beaumont Health System - Troy

Indiana

  • Indiana Spine Group - Carmel

Mississippi

  • Premier Radiology - Tupelo

Trial Details

FieldValue
Enrollment Target 354 participants
Start Date 2013-05
Est. Completion 2016-05
Phase NA
Medtronic Spinal and Biologics

26 total trials

What the finished NCT01871519 record still lists

NCT01871519 is an interventional study that assigns participants to a tested intervention. The registered 354 participants enrollment target is mid-sized for trials with a published cap, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (90% lower).

The record links to 3 conditions, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Balloon kyphoplasty is the first listed.

NCT01871519 names 20 study sites across 10 states, led by California, Illinois, Alabama.

Frequently Asked Questions

What is clinical trial NCT01871519 about?

NCT01871519 is a clinical study titled "Evaluation of Outcomes for Quality of Life and Activities of Daily Living for BKP in the Treatment of VCFs". The study objective is to collect and report 12-month outcomes pertaining to activities of daily living, quality of life, and safety parameters in a Medicare population to be treated with balloon kyphoplasty in the treatment of painful, acute, vertebral body compression fractures (VCFs) associated w...

What is the current status of trial NCT01871519?

This trial is currently completed. It is a NA study. The enrollment target is 354 participants. The study started on 2013-05. Estimated completion is 2016-05.

What conditions does trial NCT01871519 study?

This clinical trial studies the following conditions: Cancer, Osteoporosis, Compression Fracture of Vertebral Body.

What interventions are being tested in trial NCT01871519?

The interventions under investigation include: Balloon kyphoplasty (DEVICE).

Who is sponsoring clinical trial NCT01871519?

This trial is sponsored by Medtronic Spinal and Biologics, which has 26 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01871519 being conducted?

This trial has 20 study locations across Alabama, California, Florida, Idaho, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01871519's enrollment target sits among peer trials

354 163rd of 615 higher than 453 of 615 other Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02579967 · 354 participants · Phase 2

    Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies

  • NCT02610413 · 354 participants

    Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Hypertension Receiving Bevacizumab for Breast Cancer

  • NCT05729256 · 354 participants · NA

    Alcohol and "Heat of the Moment" Sexual Decision Making

  • NCT06507618 · 354 participants · Phase 3

    Pre-Operative Window of ET to Inform RT Decisions (POWER II)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT01871519, the US trial registry maintained by the National Library of Medicine. NCT01871519 (mid enrollment · wide site footprint · completed) retrieved and formatted by PlainTrial, see methodology.